Development of Clinical Decision Support System for Severe Patients With Polytrauma
Разработка системы поддержки принятия клинических решений для тяжелых больных с политравмой
1 other identifier
observational
500
1 country
1
Brief Summary
The goal of this observational study is to develop a Clinical Decision Support System for severe patients with polytrauma. The main questions it aims to answer are:
- Is it possible to predict the development of systemic inflammatory response syndrome for the next 24 h after admission?
- Is it possible to predict the development of blood loss \>25% of blood volume for the next 24 h after admission?
- Is it possible to predict the development of acute traumatic coagulopathy for the next 24 h after admission?
- Is it possible to predict the development of pneumonia in polytrauma patients?
- Is it possible to predict the outcome in polytrauma patients? No intervention is planned for this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2020
CompletedFirst Submitted
Initial submission to the registry
March 14, 2024
CompletedFirst Posted
Study publicly available on registry
March 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMarch 21, 2024
March 1, 2024
3.8 years
March 14, 2024
March 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Prediction of SIRS
Rate of SIRS prediction in the 24 h after admission using the developed CDSS.
By the end of January 2024
Rate of ATC prediction in the 24 h after admission using the developed CDSS.
Rate of ATC prediction in the 24 h after admission using the developed CDSS.
By the end of January 2024
Rate of hemorrage prediction in the 24 h after admission using the developed CDSS.
Rate of hemorrage prediction in the 24 h after admission using the developed CDSS.
By the end of January 2024
Rate of pneumonia prediction using the developed CDSS.
Rate of pneumonia prediction within all period of admission using the developed CDSS.
By the end of January 2024
Study Arms (4)
Polytrauma with SIRS
No intervention(s) to be administered.
Polytrauma with Bloodloss
No intervention(s) to be administered.
Polytrauma with ATC
No intervention(s) to be administered.
Polytrauma with Pneumonia
No intervention(s) to be administered.
Eligibility Criteria
According to the World Health Organization (WHO forecast, by 2030 trauma is one of the five leading causes of death. In the Republic of Kazakhstan, road traffic injuries rank 7th among all causes of death (14.7 \[the 10-year average is 16.9\] per 100,000 population per year). Considering geographical and epidemiological factors, we chose two regional medical centers and the National Scientific Center of Traumatology and Orthopedics in the Republic of Kazakhstan, providing emergency medical care to patients with polytrauma (the serviced population is 610,000, 1,135,000, and 1,400,000 people, respectively).
You may qualify if:
- Availability of informed consent, signed by the patient or his legal representative;
- Patients over 18 years of age;
- Expanded criteria of the new Berlin definition of polytrauma: patients who comply with three conditions:
- Presence of damage to one area of the body with an AIS score ≥3 points.
- Presence of damage to ≥2 areas of the body with an AIS score of ≥2.
- Presence of ≥1 physiological risk factors and/or primary hospitalization in the ICU.
- Completeness of the medical record in terms of laboratory and instrumental studies and protocol of therapeutic and surgical treatment.
You may not qualify if:
- Refusal to participate in the study at any stage.
- Death within one hour after hospitalization.
- Missing data.
- Patients who seek primary care 24 hours after injury.
- Patients requiring transfer between profiles and hospitals for implementation of rehabilitation or other stages of therapy.
- Patients with prematurely interrupted treatment.
- Trauma combined with suffocation, drowning, frostbite, electrical trauma, or chemical and/or thermal burns.
- Patients with pathological fractures.
- Pregnant women.
- Cases with predominantly severe craniocephalic (GCS \<7 points) or spinal injury (deep paresis and plegias).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emergency Hospital
Semey, Abai, 071400, Kazakhstan
Related Publications (1)
Prokazyuk A, Tlemissov A, Zhanaspayev M, Aubakirova S, Mussabekov A. Development and validation of a machine learning-based model to assess probability of systemic inflammatory response syndrome in patients with severe multiple traumas. BMC Med Inform Decis Mak. 2024 Aug 27;24(1):235. doi: 10.1186/s12911-024-02640-x.
PMID: 39192291DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Anesthesiology and ICU specialist
Study Record Dates
First Submitted
March 14, 2024
First Posted
March 21, 2024
Study Start
December 1, 2020
Primary Completion
September 1, 2024
Study Completion
December 31, 2024
Last Updated
March 21, 2024
Record last verified: 2024-03